Kim DK - Search Results

1

Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteers.

Jang IJ, Yu KS, Shon JH, Bae KS, Cho JY, Yi SY, Shin SG, Ryu KH, Cho YB, Kim DK, Yoo SE. Jang IJ, et al. Among authors: kim dk. J Clin Pharmacol. 2000 Jul;40(7):752-61. doi: 10.1177/00912700022009512. J Clin Pharmacol. 2000. PMID: 10883417 Clinical Trial.

2

Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamics.

Kim DK, Kim HT, Tai JH, Cho YB, Kim TS, Kim KH, Park JG, Hong WS. Kim DK, et al. Among authors: kim ts, kim ht, kim kh. Cancer Chemother Pharmacol. 1995;37(1-2):1-6. Cancer Chemother Pharmacol. 1995. PMID: 7497577

3

Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.

Kim DK, Kim HT, Cho YB, Tai JH, Ahn JS, Kim TS, Kim KH, Hong WS. Kim DK, et al. Among authors: kim ts, kim ht, kim kh. Cancer Chemother Pharmacol. 1995;35(5):441-5. doi: 10.1007/s002800050260. Cancer Chemother Pharmacol. 1995. PMID: 7850928

4

General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).

Kim DK, Ahn JS, Ryu G, Kim KH, Park CW, Kim MS, Chung MH, Shin SG, Suh YH, Kim YS. Kim DK, et al. Among authors: kim ms, kim ys, kim kh. Arzneimittelforschung. 1994 Sep;44(9):1080-8. Arzneimittelforschung. 1994. PMID: 7986249

5

Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.

Kim DK, Kim G, Gam J, Cho YB, Kim HT, Tai JH, Kim KH, Hong WS, Park JG. Kim DK, et al. Among authors: kim g, kim ht, kim kh. J Med Chem. 1994 May 13;37(10):1471-85. doi: 10.1021/jm00036a013. J Med Chem. 1994. PMID: 8182706

6

Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.

Cho YB, Kim KH, Kim DK. Cho YB, et al. Among authors: kim dk, kim kh. Drug Metab Dispos. 1995 Nov;23(11):1280-5. Drug Metab Dispos. 1995. PMID: 8591731

7

Antitumor activity of five new platinum complexes having a glycolate leaving ligand.

Hong WS, Min YI, Kim HT, Cho YB, Kim KH, Kim DK. Hong WS, et al. Among authors: kim dk, kim ht, kim kh. J Korean Med Sci. 1995 Aug;10(4):269-74. doi: 10.3346/jkms.1995.10.4.269. J Korean Med Sci. 1995. PMID: 8593207 Free PMC article.

8

In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).

Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS. Kim DK, et al. Among authors: kim ts, kim ht, kim kh. Anticancer Res. 1996 Jan-Feb;16(1):251-6. Anticancer Res. 1996. PMID: 8615617

9

Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogs.

Kim DK, Cho YB, Kim HT, Kim TS, Kim KH, Hong WS. Kim DK, et al. Among authors: kim ts, kim ht, kim kh. Anticancer Res. 1996 May-Jun;16(3A):1167-9. Anticancer Res. 1996. PMID: 8702230

10

Pharmacokinetics of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in rats.

Cho YB, Kim DK, Kim KH, Miyamoto G. Cho YB, et al. Among authors: kim dk, kim kh. Arzneimittelforschung. 1996 Jun;46(6):629-34. Arzneimittelforschung. 1996. PMID: 8767356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,983 results

Search Page

Filters